JAZZ
Jazz Pharmaceuticals plc
Stock
$235.67+2.66 (+1.14%)Close Oct 2, 2026
- Revenue, 2025
- $4.3B
- YoY, 2025
- +4.9%
- 5-year CAGR
- +12.5%
- 10-year CAGR
- +12.4%
Revenue
Revenue by fiscal year
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $4.3B | +4.9% |
| 2024 | $4.1B | +6.1% |
| 2023 | $3.8B | +4.8% |
| 2022 | $3.7B | +18.3% |
| 2021 | $3.1B | +30.9% |
| 2020 | $2.4B | +9.3% |
| 2019 | $2.2B | +14.3% |
| 2018 | $1.9B | +16.8% |
| 2017 | $1.6B | +8.8% |
| 2016 | $1.5B | +12.3% |
| 2015 | $1.3B | +13.0% |
| 2014 | $1.2B | +34.4% |
| 2013 | $872M | +48.9% |
| 2012 | $586M | +115.2% |
| 2011 | $272M | +56.7% |
| 2010 | $174M | +35.3% |
| 2009 | $128M | — |